Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug...
Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug...
Check out some of the companies making the biggest moves in midday trading. Bank stocks — The group fell broadly...
Lights on in skyscrapers and commercial buildings on the skyline of the City of London, UK, on Tuesday, Nov. 18,...